Both in Biotechnology
Scribe Therapeutics vs Eikon Therapeutics
Over the past year SCTX returned −48.0% and EIKN returned −39.4%; their daily moves had a correlation of 0.19.
SCTX −48.0% EIKN −39.4%Growth of $1, one year, split-adjusted
| Metric | SCTX | EIKN |
|---|---|---|
| Price | $15.47 | $5.42 |
| Market cap | $292.9M | $293.6M |
| Today | +0.32% | +2.07% |
| 1 month | −7.9% | −26.1% |
| 6 months | — | −47.2% |
| Year to date | — | — |
| 1 year | — | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | $531.2M |
| Dividend yield | — | — |
| Volatility (60d) | — | 99.5% |
| Short % of float | 14.6% | 20.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).